Through our collective efforts, we truly believe that we can build a future where college students recognize their risk for influenza, are motivated to get vaccinated annually, and feel empowered to build healthy habits for a lifetime.
Thanksgiving is typically a time to sit back, relax, enjoy the fall weather, and spend time with family. It is also a good time to think about what makes you most thankful. This Thanksgiving, I am thankful for my health and am reminded of the importance of staying healthy as a parent of teenage twin daughters. One of the easiest steps I can take to ensure that I stay healthy for my children is to stay current on all recommended vaccines.
Through our collective efforts we can help routinize using the 16-year-old visit to include recommended and catch-up vaccines. Together, we can help healthcare professionals and the public become more aware of, and motivated to comply with, US vaccine recommendations and, ultimately, help protect older teens against vaccine-preventable diseases.
Now is the time for parents and health professionals to protect the children they care for from HPV cancers. Every year that adolescents aren’t vaccinated is another year they are unprotected from cancer-causing infections…
Teens who feel invincible and put up a fight about a potentially painful shot should be no match for medical providers who can stand firm on the importance of vaccination. After all, many adolescents (and their parents) don’t understand what’s at stake if they opt out of a vaccine. Take it from a survivor of a vaccine-preventable disease: vaccines are unspeakably important and must be made a priority.
Unity recently released the results of a national survey of parents of teens, teens, and healthcare providers underscoring that misperceptions about preventive health and vaccines may contribute to under-vaccination of teens. While a vast majority of parents and teens believe it is important for all teens to be vaccinated, in reality teen vaccination rates are lower than they should be…
The permissive (Category B) recommendation for meningococcal serogroup B vaccination reflects the science of the disease, takes into account many practical issues in vaccine delivery, and offers the widest range of solutions for patients and their families, healthcare providers, and the healthcare system.
Adding a vaccine to the recommended schedule is not without controversy. All vaccines cost money—the meningococcal B vaccine costs around $130 a dose and currently the two vaccines available are part of a 2- or 3-dose series. However, the benefits of vaccination far out weigh the cost of vaccination.